Compare ABUS & AEHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABUS | AEHR |
|---|---|---|
| Founded | 2005 | 1977 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electrical Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 888.5M | 858.8M |
| IPO Year | N/A | 1997 |
| Metric | ABUS | AEHR |
|---|---|---|
| Price | $4.17 | $28.49 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | $5.00 | ★ $21.00 |
| AVG Volume (30 Days) | ★ 2.1M | 1.4M |
| Earning Date | 03-26-2026 | 01-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $14,606,000.00 | ★ $53,249,000.00 |
| Revenue This Year | $125.30 | N/A |
| Revenue Next Year | N/A | $60.20 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 116.64 | 4.96 |
| 52 Week Low | $2.71 | $6.27 |
| 52 Week High | $5.10 | $37.49 |
| Indicator | ABUS | AEHR |
|---|---|---|
| Relative Strength Index (RSI) | 48.44 | 53.24 |
| Support Level | $3.85 | $22.66 |
| Resistance Level | $4.26 | $37.49 |
| Average True Range (ATR) | 0.33 | 3.21 |
| MACD | 0.02 | 0.14 |
| Stochastic Oscillator | 58.18 | 38.91 |
Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.
Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets. The Company operates in one business segment, the designing, manufacturing, marketing and selling of advanced test and burn-in products to the semiconductor manufacturing industry in several geographic areas. The company provides production solutions across the product manufacturing flow to improve yield and reliability and has developed and introduced several inventive products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.